Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

aap Implantate (0N5A) Price & Analysis

0N5A Stock Chart & Stats

€1.46€0.00(0.00%)
At close: 4:00 PM EDT
EUR 1.4EUR 1.5EUR 1.6EUR 1.713 Jul27 Jul7 Aug24 Aug4 Sep21 Sep7 Oct
Day’s Range
EUR 1.46 - EUR 1.46
52-Week Range
EUR 1.35 - EUR 2.34
Previous Close
EUR 1.46
Volume
9
Average Volume (3M)
0
Market Cap
EUR 21.34M
Enterprise Value
EUR 28.81M
Total Cash (Recent Filing)
EUR 286.00K
Total Debt (Recent Filing)
EUR 3.97M
Price to Earnings (P/E)
―
Beta
0.46
Next Earnings
Aug 18, 2027
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Strong Gross Margin

An approximately 82% gross margin indicates strong product-level economics in the orthopedic implant business. This provides a meaningful base for covering operating costs and funding commercial activity, while also leaving potential for improved earnings if the company can achieve better cost discipline and scale.

Manageable Leverage

Low debt relative to equity limits balance-sheet pressure and reduces dependence on borrowing to sustain operations. Positive, sizable equity provides a cushion against continuing losses and preserves greater financial flexibility for restructuring, investment, or controlled growth over the next several quarters.

Specialized Orthopedic Positioning

A focused portfolio of orthopedic implants and related surgical solutions gives the company a defined position in a specialized medical-technology market. Procedure-linked implants and supporting instruments can support recurring clinical demand when products remain relevant to surgeons and hospitals.

Bears Say

Persistent Unprofitability

Persistent net losses show that strong gross profitability has not yet translated into a self-sustaining earnings model. Continued operating losses can consume equity, restrict investment capacity, and leave the company dependent on future operational improvement or external funding to support its strategy.

Ongoing Cash Burn

Negative operating and free cash flow indicate that the core business is not currently funding itself. Continued cash consumption reduces financial resilience, may require additional financing or cost reductions, and limits the company’s ability to invest in products and market expansion without outside support.

Revenue Momentum Weakening

The TTM revenue decline suggests weakening commercial momentum after a relatively stable revenue base. Lower sales can reduce operating leverage and make it harder to absorb fixed costs, increasing the challenge of converting the company’s high gross margin into sustainable profitability.

0N5A FAQ

What was aap Implantate’s price range in the past 12 months?
aap Implantate lowest share price was €1.35 and its highest was €2.34 in the past 12 months.
What is aap Implantate’s market cap?
aap Implantate’s market cap is €21.34M.
When is aap Implantate’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were aap Implantate’s earnings last quarter?
aap Implantate released its earnings results on Aug 17, 2026. The company reported -€0.078 earnings per share for the quarter.
Is aap Implantate overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does aap Implantate pay dividends?
aap Implantate does not currently pay dividends.
What is aap Implantate’s EPS estimate?
aap Implantate’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does aap Implantate have?
aap Implantate has 14,716,976 shares outstanding.
What happened to aap Implantate’s price movement after its last earnings report?
aap Implantate reported an EPS of -€0.078 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of aap Implantate?
Currently, no hedge funds are holding shares in GB:0N5A
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology